Hematopoietic Stem Cell Risks To Donor (G-CSF, GM-CSF)

Risks to donor Of Hematopoietic stem cell

There Are Five Part Of Risks To Donor Of  Hematopoietic Stem Cell 

Risks To Donor : 

The risks of a complication depend on patient characteristics, health care providers and the apheresis procedure, and the colony-stimulating factor used (G-CSF, GM-CSF). G-CSF drugs include filgrastim (Neupogen, Neulasta), and lenograstim (Graslopin).

1. Drug risks
2. Access risks
3. Clinical observations
4. Severe reactions
5. Donor registration and recruitment